Hopkinton, MA and San Diego, CA 2/26/08—Caliper Life Sciences has entered into a settlement agreement with AntiCancer, resolving the patent infringement suit that AntiCancer brought against Xenogen in 2005. Caliper acquired Xenogen in 2006 (see IBO 2/15/06). Under the settlement, Caliper acquired the right to sublicense AntiCancer’s fluorescent protein optical imaging patents, and AntiCancer acquired […]

Carlsbad and Santa Clara, CA 2/5/08—Invitrogen and Agilent have reached a confidential agreement to settle three lawsuits. Stratagene, which Agilent acquired last year (see IBO 4/15/07), was a party in all three suits. Under the agreement, Agilent will make a payment to Invitrogen for an undisclosed amount and discontinue sales of RNase H minus reverse […]

San Diego and Santa Clara, CA 1/10/08—Affymetrix and Illumina have signed a settlement agreement, ending their four-year patent dispute. Under the agreement, Illumina will make a one-time payment of $90 million to Affymetrix without admitting liability. In exchange, Affymetrix has granted Illumina, its affiliates and its customers a perpetual covenant not to file suit for […]

San Diego, CA 12/21/0—-Illumina has announced that the US Patent and Trademark Office (USPTO) will reexamine four of the five patents (US Patent Nos. 5,545,531; 5,795,716; 6,355,432 and 6,646,243) that are the subject of Affymetrix’s patent infringement suit against the company. In March, a jury ruled in favor of Affymetrix, finding that Illumina infringed or […]